Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults
JAMA Network Open · 28.10.2024 · 7 (10) · e2441970
DOI: 10.1001/jamanetworkopen.2024.41970 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 28.10.2024. Verfasst von Ting Zhou und 34 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: COVID-19, Body Mass Index, SARS-CoV-2. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIMH NIH HHS, NIA NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance Obesity is associated with increased severity of COVID-19. Whether obesity is associated with an increased risk of post-acute sequelae of SARS-CoV-2 infection (PASC) among pediatric populations, independent of its association with acute infection severity, is unclear.
Objective
To quantify the association of body mass index (BMI) status before SARS-CoV-2 infection with pediatric PASC risk, controlling for acute infection severity. Design, Setting, and Participants This retrospective cohort study occurred at 26 US children’s hospitals from March 2020 to May 2023 with a minimum follow-up of 179 days. Eligible participants included children and young adults aged 5 to 20 years with SARS-CoV-2 infection. Data analysis was conducted from October 2023 to January 2024. Exposures BMI status assessed within 18 months before infection; the measure closest to the index date was selected. The BMI categories included healthy weight (≥5th to <85th percentile for those aged 5-19 years or ≥18.5 to <25 for those aged >19 years), overweight (≥85th to <95th percentile for those aged 5-19 years or ≥25 to <30 for for those aged >19 years), obesity (≥95th percentile to <120% of the 95th percentile for for those aged 5-19 years or ≥30 to <40 for those aged >19 years), and severe obesity (≥120% of the 95th percentile for those aged 5-19 years or ≥40 for those aged >19 years). Main Outcomes And Measures To identify PASC, a diagnostic code specific for post–COVID-19 conditions was used and a second approach used clusters of symptoms and conditions that constitute the PASC phenotype. Relative risk (RR) for the association of BMI with PASC was quantified by Poisson regression models, adjusting for sociodemographic, acute COVID severity, and other clinical factors.
Results
A total of 172 136 participants (mean [SD] age at BMI assessment 12.6 [4.4] years; mean [SD] age at cohort entry, 13.1 [4.4] years; 90 187 female [52.4%]) were included. Compared with participants with healthy weight, those with obesity had a 25.4% increased risk of PASC (RR, 1.25; 95% CI, 1.06-1.48) and those with severe obesity had a 42.1% increased risk of PASC (RR, 1.42; 95% CI, 1.25-1.61) when identified using the diagnostic code. Compared with those with healthy weight, there was an increased risk for any occurrences of PASC symptoms and conditions among those with obesity (RR, 1.11; 95% CI, 1.06-1.15) and severe obesity (RR, 1.17; 95% CI, 1.14-1.21), and the association held when assessing total incident occurrences among those with overweight (RR, 1.05; 95% CI, 1.00-1.11), obesity (RR, 1.13; 95% CI, 1.09-1.19), and severe obesity (RR, 1.18; 95% CI, 1.14-1.22).
Conclusions
And Relevance In this cohort study, elevated BMI was associated with a significantly increased PASC risk in a dose-dependent manner, highlighting the need for targeted care to prevent chronic conditions in at-risk children and young adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia.
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia.
- Department of Biostatistics and Health Data Science, University of Pittsburgh, Pittsburgh, Pennsylvania.
- Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- Department of Population Health, New York University Grossman School of Medicine, New York.
Förderung
- NCATS NIH HHS
- NIMH NIH HHS
- NIA NIH HHS
- NLM NIH HHS
- NIAID NIH HHS
- NEI NIH HHS
Zitieren
APA
Zhou, T., Zhang, B., Zhang, D., Wu, Q., Chen, J., Li, L., Lu, Y., Becich, M. J., Blecker, S., Chilukuri, N., Chrischilles, E. A., Chu, H., Corsino, L., Geary, C. R., Hornig, M., Hornig-Rohan, M. M., Kim, S., Liebovitz, D. M., Lorman, V., …, & Chen, Y. (2024). Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults. JAMA Network Open, 7(10), e2441970. https://doi.org/10.1001/jamanetworkopen.2024.41970
Vancouver
Zhou T, Zhang B, Zhang D, Wu Q, Chen J, Li L, et al. Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults. JAMA Network Open. 2024;7(10):e2441970. doi:10.1001/jamanetworkopen.2024.41970
BibTeX
@article{Zhou2024,
author = {Zhou, Ting and Zhang, Bingyu and Zhang, Dazheng and Wu, Qiong and Chen, Jiajie and Li, Lu and Lu, Yiwen and Becich, Michael J and Blecker, Saul and Chilukuri, Nymisha and Chrischilles, Elizabeth A and Chu, Haitao and Corsino, Leonor and Geary, Carol R and Hornig, Mady and Hornig-Rohan, Maxwell M and Kim, Susan and Liebovitz, David M and Lorman, Vitaly and Luo, Chongliang and Morizono, Hiroki and Mosa, Abu S M and Pajor, Nathan M and Rao, Suchitra and Razzaghi, Hanieh and Suresh, Srinivasan and Tedla, Yacob G and Utset, Leah Vance and Wang, Youfa and Williams, David A and Witvliet, Margot Gage and Mangarelli, Caren and Jhaveri, Ravi and Forrest, Christopher B and Chen, Yong},
title = {Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {10},
pages = {e2441970},
doi = {10.1001/jamanetworkopen.2024.41970}
}
EUVIMED